In the News

1837 News Items found
Memorial Sloan Kettering Chief Medical Epidemiologist Mini Kamboj
Women Leaders at MSK: Mini Kamboj
Mini Kamboj says encouragement from her family during her early years help mold her into the strong, self-possessed leader needed to guide MSK through the COVID-19 pandemic.
Damien Scogin is seen outdoors with his 9-year-old daughter, Jane. Damien is being treated at MSK’s Center for Young Onset Colorectal and Gastrointestinal Cancer, the first center in the world devoted to people under 50 with these types of cancer.
‘Aren’t I Too Young?’ How MSK Helps People under 50 with Colorectal and GI Cancers
Learn more about the first facility in the world devoted to the specific needs of colorectal cancer patients under the age of 50.
Leukemia expert Anthony Mato
Researchers Report Excellent Outcomes for New Leukemia and Lymphoma Drug
The first-ever clinical trial of a new kind of drug, called pirtobrutinib or LOXO-305, has shown promising results in a phase I/II study.
Feature
Developmental biologist Kathryn Anderson
In Memoriam: Developmental Biologist Kathryn V. Anderson
Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute.
David Scheinberg and Lisa DeAngelis
MSK a Founding Member of Break Through Cancer
MSK is a founding member of Break Through Cancer, a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers.
In the Lab
Physician-scientist Luc Morris
Clearing the Fog around Tumor Mutational Burden
MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs.
Carol Brown, MD
Carol Brown, MD, Named a Notable Black Executive by Crain’s
Gynecologic cancer surgeon Carol Brown featured in Crain's New York Business’ Notable Black Leaders and Executives list.
Dr. Robert Motzer speaks to a patient
Making Progress in Genitourinary Cancers: MSK Physicians Share Research Advances at Annual ASCO GU Symposium
MSK's Robert Motzer presented positive data from a phase III randomized study that assessed two different treatment combinations as first-line therapies that may benefit people with advanced kidney cancer.
Finding
Genetic counselor Elise Fiala and pediatric cancer expert Michael Walsh
Study Demonstrates the Reasons to Screen Children with Cancer for Inherited Cancer Genes
The largest study of its kind to look at data from children with cancer finds inherited cancer genes are more common than expected.
Roberta Zappasodi, Taha Merghoub, and Jedd Wolchok. Photo credit: Flynn Larsen for Ludwig Cancer Research
To Improve Immunotherapy, Researchers Look to Shift Immune Cells’ Access to Sugar
More sugar available for immune cells could mean better immune responses against cancer.